ContraFect Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
“Combinations of CF-301 with vancomycin or daptomycin increased survival significantly in animal models of disease when compared to treatment with SOC antibiotics or CF-301 alone.”
ContraFect Corp. is a clinical-stage biotechnology company. It focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. The company scientific and clinical strategy focuses on the use of combination therapies. ContraFect was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY. [Source: MarketWatch]
Company Website: http://www.contrafect.com